Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs].
Will Biomarkers Determine What Is Next in Multiple Sclerosis?: Biomarkers in Multiple Sclerosis.
Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions.
Head Tracking Latency in Virtual Environments Revisited: Do Users with Multiple Sclerosis Notice Latency Less?
Chemokine receptor expression of T cells in the cerebrospinal fluid of relapsing multiple sclerosis.
Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression.
Comparison of regular aerobic and yoga on the quality of life in patients with multiple sclerosis.
Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report.
Longitudinally extensive varicella-zoster virus myelitis in a multiple sclerosis patient.
Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites.
Simplified scoring of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: a comparative analysis of test performance at different cut-off points.
The dual task-cost of standing balance affects quality of life in mildly disabled MS people.
Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
Fingolimod and multiple sclerosis: Four cautionary tales.
Occupational attainment as a marker of cognitive reserve in multiple sclerosis.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
Cell-Based Reporter Gene Assay for Therapy-Induced Neutralizing Antibodies to Interferon-Beta in Multiple Sclerosis.
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls.
Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6.
Using historical control information for the design and analysis of clinical trials with overdispersed count data.
Ascl1/Mash1 Promotes Brain Oligodendrogenesis during Myelination and Remyelination.
Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.

Pages